Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruud van Stiphout

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Cellular Oncology (Dordrecht, Netherlands)|December 20, 2022
WNT5A-ROR2 axis mediates VEGF dependence of BRAF mutant melanomaNicholas Coupe, Lina Guo, Esther Bridges, et al.
Cancer Research|August 3, 2017
Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic CancerZenobia D'Costa, Keaton Jones, Abul Azad, et al.
Oncotarget|January 22, 2015
Hypoxia induces a lipogenic cancer cell phenotype via HIF1α-dependent and -independent pathwaysAlessandro Valli, Miguel Rodriguez, Loukas Moutsianas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 9, 2021
The Novel Nucleoside Analogue ProTide NUC-7738 Overcomes Cancer Resistance Mechanisms <i>In Vitro</i> and in a First-In-Human Phase I Clinical TrialHagen Schwenzer, Erica De Zan, Mustafa Elshani, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Cellular Oncology (Dordrecht, Netherlands)|December 20, 2022
WNT5A-ROR2 axis mediates VEGF dependence of BRAF mutant melanomaNicholas Coupe, Lina Guo, Esther Bridges, et al.
Cancer Research|August 3, 2017
Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic CancerZenobia D'Costa, Keaton Jones, Abul Azad, et al.
Oncotarget|January 22, 2015
Hypoxia induces a lipogenic cancer cell phenotype via HIF1α-dependent and -independent pathwaysAlessandro Valli, Miguel Rodriguez, Loukas Moutsianas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 9, 2021
The Novel Nucleoside Analogue ProTide NUC-7738 Overcomes Cancer Resistance Mechanisms <i>In Vitro</i> and in a First-In-Human Phase I Clinical TrialHagen Schwenzer, Erica De Zan, Mustafa Elshani, et al.
Pageof 2